Sphingosine kinase: a key to solving the ‘French Paradox’?

Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond

(2012) Kenneth C. Loh et al.   Anti-Cancer Agents in Medicinal Chemistry

Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival

(2012) Keng Gat Lim et al.   BRITISH JOURNAL OF PHARMACOLOGY

Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth

(2012) Daniela Hartmann et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules

(2011) S. Pyne et al.   CANCER RESEARCH

Development of Amidine-Based Sphingosine Kinase 1 Nanomolar Inhibitors and Reduction of Sphingosine 1-Phosphate in Human Leukemia Cells

(2011) Andrew J. Kennedy et al.   JOURNAL OF MEDICINAL CHEMISTRY

Translational aspects of sphingosine 1-phosphate biology

(2011) Susan Pyne et al.   TRENDS IN MOLECULAR MEDICINE

Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance

(2010) Suriyan Ponnusamy et al.   Future Oncology